News OEM

Supporting your Immunoassay portfolio expansion

Biomaterials for immunoassay development & manufacturing

July 13, 2023


Supporting your immunoassay portfolio expansion

Biomaterials for immunoassay development & manufacturing

When developing a new immunoassay, having a deep knowledge of the biomaterial helps to optimize R&D resources. And what is more, it helps reduce the risk in later stages of the project, where significant commitments are made and the cost of responding to unexpected events increases exponentially.  

Our experience in immunoassay development and manufacturing helps us understand the challenges you might face as an immunoassay developer & manufacturer.

How Werfen can support you

In Werfen, we can support your portfolio expansion by supplying reliable biomaterials that have already been used in different immunoassay technologies.

Following our strategy to expand and diversify our biomaterials’ portfolio, we have added more than 15 new antigens and antibodies in our catalog. Moreover, for some of the new biomaterials developed, we have included in the availability of prototype samples. By supplying samples at R&D stage, our partners can assess the performance of the biomaterial at initial steps of the development and reduce risks in later stages of the project.



Share Press Release:

LinkedIn twitter facebook
Contact us

Please contact us directly via telephone or with the following form.

Tel. +34 93 860 90 00


Biokit, S.A. and Biokit Research & Development, S.L.U. will process your personal data to respond to your requests for information or support, or to understand your needs and provide you with a better service relying on our legitimate interest to do so. You can find more information about our data privacy practices and how to exercise your rights in our Privacy Policy. You can also contact us at